Eintrag weiter verarbeiten
Higher incidence of severe hypoglycaemia leading to hospital admission in Type 2 diabetic patients treated with long‐acting versus short‐acting sulphonylureas
Gespeichert in:
| Zeitschriftentitel: | Diabetic Medicine |
|---|---|
| Personen und Körperschaften: | , |
| In: | Diabetic Medicine, 16, 1999, 7, S. 586-590 |
| Format: | E-Article |
| Sprache: | Englisch |
| veröffentlicht: |
Wiley
|
| Schlagwörter: |
| author_facet |
Stahl, M. Berger, W. Stahl, M. Berger, W. |
|---|---|
| author |
Stahl, M. Berger, W. |
| spellingShingle |
Stahl, M. Berger, W. Diabetic Medicine Higher incidence of severe hypoglycaemia leading to hospital admission in Type 2 diabetic patients treated with long‐acting versus short‐acting sulphonylureas Endocrinology Endocrinology, Diabetes and Metabolism Internal Medicine |
| author_sort |
stahl, m. |
| spelling |
Stahl, M. Berger, W. 0742-3071 1464-5491 Wiley Endocrinology Endocrinology, Diabetes and Metabolism Internal Medicine http://dx.doi.org/10.1046/j.1464-5491.1999.00110.x <jats:title>Summary</jats:title><jats:p> <jats:bold>Aims</jats:bold> A comparison of the frequency of severe hypoglycaemia leading to hospital admission in people with Type 2 diabetes mellitus (DM) treated with long vs. short‐acting sulphonylureas.</jats:p><jats:p> <jats:bold>Methods</jats:bold> A community based study over a 12‐year period in the population of the city of Basle, Switzerland. The number of diabetic patients treated with oral hypoglycaemic agents was established on the basis of tablet consumption and a defined daily dose, e.g. 7.5 mg for glibenclamide, and 50 mg for glibornuride.</jats:p><jats:p> <jats:bold>Results</jats:bold> Twenty‐eight Type 2 diabetic patients were admitted for severe hypo‐ glycaemia, with a median age of 73 years. There were no deaths. Sixteen of these admissions were patients treated with long‐acting sulphonylureas and 12 were patients treated with short‐acting forms. Only 23.5% of the population with Type 2 DM in Basle were treated with long‐acting sulphonylureas. With 30 345 person‐years of observation, the incidence of severe hypoglycaemia was 2.24 per 1000 person‐years for long‐acting sulphonylureas vs. 0.75 per 1000 person‐year for short‐acting forms, odds ratio 3.01 (95% confidence interval 1.35–6.77). Decreased food intake (nine patients) was a major contributing factor.</jats:p><jats:p> <jats:bold>Conclusions</jats:bold> Severe hypoglycaemia leading to hospital admission is more common in elderly Type 2 diabetic patients treated with long‐acting compared to short‐acting sulphonylureas. Such long‐acting sulphonylureas should be avoided.</jats:p> Higher incidence of severe hypoglycaemia leading to hospital admission in Type 2 diabetic patients treated with long‐acting versus short‐acting sulphonylureas Diabetic Medicine |
| doi_str_mv |
10.1046/j.1464-5491.1999.00110.x |
| facet_avail |
Online |
| finc_class_facet |
Medizin |
| format |
ElectronicArticle |
| fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA0Ni9qLjE0NjQtNTQ5MS4xOTk5LjAwMTEwLng |
| id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA0Ni9qLjE0NjQtNTQ5MS4xOTk5LjAwMTEwLng |
| institution |
DE-105 DE-14 DE-Ch1 DE-L229 DE-D275 DE-Bn3 DE-Brt1 DE-D161 DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 |
| imprint |
Wiley, 1999 |
| imprint_str_mv |
Wiley, 1999 |
| issn |
0742-3071 1464-5491 |
| issn_str_mv |
0742-3071 1464-5491 |
| language |
English |
| mega_collection |
Wiley (CrossRef) |
| match_str |
stahl1999higherincidenceofseverehypoglycaemialeadingtohospitaladmissionintype2diabeticpatientstreatedwithlongactingversusshortactingsulphonylureas |
| publishDateSort |
1999 |
| publisher |
Wiley |
| recordtype |
ai |
| record_format |
ai |
| series |
Diabetic Medicine |
| source_id |
49 |
| title |
Higher incidence of severe hypoglycaemia leading to hospital admission in Type 2 diabetic patients treated with long‐acting versus short‐acting sulphonylureas |
| title_unstemmed |
Higher incidence of severe hypoglycaemia leading to hospital admission in Type 2 diabetic patients treated with long‐acting versus short‐acting sulphonylureas |
| title_full |
Higher incidence of severe hypoglycaemia leading to hospital admission in Type 2 diabetic patients treated with long‐acting versus short‐acting sulphonylureas |
| title_fullStr |
Higher incidence of severe hypoglycaemia leading to hospital admission in Type 2 diabetic patients treated with long‐acting versus short‐acting sulphonylureas |
| title_full_unstemmed |
Higher incidence of severe hypoglycaemia leading to hospital admission in Type 2 diabetic patients treated with long‐acting versus short‐acting sulphonylureas |
| title_short |
Higher incidence of severe hypoglycaemia leading to hospital admission in Type 2 diabetic patients treated with long‐acting versus short‐acting sulphonylureas |
| title_sort |
higher incidence of severe hypoglycaemia leading to hospital admission in type 2 diabetic patients treated with long‐acting versus short‐acting sulphonylureas |
| topic |
Endocrinology Endocrinology, Diabetes and Metabolism Internal Medicine |
| url |
http://dx.doi.org/10.1046/j.1464-5491.1999.00110.x |
| publishDate |
1999 |
| physical |
586-590 |
| description |
<jats:title>Summary</jats:title><jats:p> <jats:bold>Aims</jats:bold> A comparison of the frequency of severe hypoglycaemia leading to hospital admission in people with Type 2 diabetes mellitus (DM) treated with long vs. short‐acting sulphonylureas.</jats:p><jats:p> <jats:bold>Methods</jats:bold> A community based study over a 12‐year period in the population of the city of Basle, Switzerland. The number of diabetic patients treated with oral hypoglycaemic agents was established on the basis of tablet consumption and a defined daily dose, e.g. 7.5 mg for glibenclamide, and 50 mg for glibornuride.</jats:p><jats:p> <jats:bold>Results</jats:bold> Twenty‐eight Type 2 diabetic patients were admitted for severe hypo‐ glycaemia, with a median age of 73 years. There were no deaths. Sixteen of these admissions were patients treated with long‐acting sulphonylureas and 12 were patients treated with short‐acting forms. Only 23.5% of the population with Type 2 DM in Basle were treated with long‐acting sulphonylureas. With 30 345 person‐years of observation, the incidence of severe hypoglycaemia was 2.24 per 1000 person‐years for long‐acting sulphonylureas vs. 0.75 per 1000 person‐year for short‐acting forms, odds ratio 3.01 (95% confidence interval 1.35–6.77). Decreased food intake (nine patients) was a major contributing factor.</jats:p><jats:p> <jats:bold>Conclusions</jats:bold> Severe hypoglycaemia leading to hospital admission is more common in elderly Type 2 diabetic patients treated with long‐acting compared to short‐acting sulphonylureas. Such long‐acting sulphonylureas should be avoided.</jats:p> |
| container_issue |
7 |
| container_start_page |
586 |
| container_title |
Diabetic Medicine |
| container_volume |
16 |
| format_de105 |
Article, E-Article |
| format_de14 |
Article, E-Article |
| format_de15 |
Article, E-Article |
| format_de520 |
Article, E-Article |
| format_de540 |
Article, E-Article |
| format_dech1 |
Article, E-Article |
| format_ded117 |
Article, E-Article |
| format_degla1 |
E-Article |
| format_del152 |
Buch |
| format_del189 |
Article, E-Article |
| format_dezi4 |
Article |
| format_dezwi2 |
Article, E-Article |
| format_finc |
Article, E-Article |
| format_nrw |
Article, E-Article |
| _version_ |
1792339414650716164 |
| geogr_code |
not assigned |
| last_indexed |
2024-03-01T15:47:45.546Z |
| geogr_code_person |
not assigned |
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Higher+incidence+of+severe+hypoglycaemia+leading+to+hospital+admission+in+Type+2+diabetic+patients+treated+with+long%E2%80%90acting+versus+short%E2%80%90acting+sulphonylureas&rft.date=1999-07-01&genre=article&issn=1464-5491&volume=16&issue=7&spage=586&epage=590&pages=586-590&jtitle=Diabetic+Medicine&atitle=Higher+incidence+of+severe+hypoglycaemia+leading+to+hospital+admission+in+Type+2+diabetic+patients+treated+with+long%E2%80%90acting+versus+short%E2%80%90acting+sulphonylureas&aulast=Berger&aufirst=W.&rft_id=info%3Adoi%2F10.1046%2Fj.1464-5491.1999.00110.x&rft.language%5B0%5D=eng |
| SOLR | |
| _version_ | 1792339414650716164 |
| author | Stahl, M., Berger, W. |
| author_facet | Stahl, M., Berger, W., Stahl, M., Berger, W. |
| author_sort | stahl, m. |
| container_issue | 7 |
| container_start_page | 586 |
| container_title | Diabetic Medicine |
| container_volume | 16 |
| description | <jats:title>Summary</jats:title><jats:p> <jats:bold>Aims</jats:bold> A comparison of the frequency of severe hypoglycaemia leading to hospital admission in people with Type 2 diabetes mellitus (DM) treated with long vs. short‐acting sulphonylureas.</jats:p><jats:p> <jats:bold>Methods</jats:bold> A community based study over a 12‐year period in the population of the city of Basle, Switzerland. The number of diabetic patients treated with oral hypoglycaemic agents was established on the basis of tablet consumption and a defined daily dose, e.g. 7.5 mg for glibenclamide, and 50 mg for glibornuride.</jats:p><jats:p> <jats:bold>Results</jats:bold> Twenty‐eight Type 2 diabetic patients were admitted for severe hypo‐ glycaemia, with a median age of 73 years. There were no deaths. Sixteen of these admissions were patients treated with long‐acting sulphonylureas and 12 were patients treated with short‐acting forms. Only 23.5% of the population with Type 2 DM in Basle were treated with long‐acting sulphonylureas. With 30 345 person‐years of observation, the incidence of severe hypoglycaemia was 2.24 per 1000 person‐years for long‐acting sulphonylureas vs. 0.75 per 1000 person‐year for short‐acting forms, odds ratio 3.01 (95% confidence interval 1.35–6.77). Decreased food intake (nine patients) was a major contributing factor.</jats:p><jats:p> <jats:bold>Conclusions</jats:bold> Severe hypoglycaemia leading to hospital admission is more common in elderly Type 2 diabetic patients treated with long‐acting compared to short‐acting sulphonylureas. Such long‐acting sulphonylureas should be avoided.</jats:p> |
| doi_str_mv | 10.1046/j.1464-5491.1999.00110.x |
| facet_avail | Online |
| finc_class_facet | Medizin |
| format | ElectronicArticle |
| format_de105 | Article, E-Article |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_de520 | Article, E-Article |
| format_de540 | Article, E-Article |
| format_dech1 | Article, E-Article |
| format_ded117 | Article, E-Article |
| format_degla1 | E-Article |
| format_del152 | Buch |
| format_del189 | Article, E-Article |
| format_dezi4 | Article |
| format_dezwi2 | Article, E-Article |
| format_finc | Article, E-Article |
| format_nrw | Article, E-Article |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA0Ni9qLjE0NjQtNTQ5MS4xOTk5LjAwMTEwLng |
| imprint | Wiley, 1999 |
| imprint_str_mv | Wiley, 1999 |
| institution | DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1 |
| issn | 0742-3071, 1464-5491 |
| issn_str_mv | 0742-3071, 1464-5491 |
| language | English |
| last_indexed | 2024-03-01T15:47:45.546Z |
| match_str | stahl1999higherincidenceofseverehypoglycaemialeadingtohospitaladmissionintype2diabeticpatientstreatedwithlongactingversusshortactingsulphonylureas |
| mega_collection | Wiley (CrossRef) |
| physical | 586-590 |
| publishDate | 1999 |
| publishDateSort | 1999 |
| publisher | Wiley |
| record_format | ai |
| recordtype | ai |
| series | Diabetic Medicine |
| source_id | 49 |
| spelling | Stahl, M. Berger, W. 0742-3071 1464-5491 Wiley Endocrinology Endocrinology, Diabetes and Metabolism Internal Medicine http://dx.doi.org/10.1046/j.1464-5491.1999.00110.x <jats:title>Summary</jats:title><jats:p> <jats:bold>Aims</jats:bold> A comparison of the frequency of severe hypoglycaemia leading to hospital admission in people with Type 2 diabetes mellitus (DM) treated with long vs. short‐acting sulphonylureas.</jats:p><jats:p> <jats:bold>Methods</jats:bold> A community based study over a 12‐year period in the population of the city of Basle, Switzerland. The number of diabetic patients treated with oral hypoglycaemic agents was established on the basis of tablet consumption and a defined daily dose, e.g. 7.5 mg for glibenclamide, and 50 mg for glibornuride.</jats:p><jats:p> <jats:bold>Results</jats:bold> Twenty‐eight Type 2 diabetic patients were admitted for severe hypo‐ glycaemia, with a median age of 73 years. There were no deaths. Sixteen of these admissions were patients treated with long‐acting sulphonylureas and 12 were patients treated with short‐acting forms. Only 23.5% of the population with Type 2 DM in Basle were treated with long‐acting sulphonylureas. With 30 345 person‐years of observation, the incidence of severe hypoglycaemia was 2.24 per 1000 person‐years for long‐acting sulphonylureas vs. 0.75 per 1000 person‐year for short‐acting forms, odds ratio 3.01 (95% confidence interval 1.35–6.77). Decreased food intake (nine patients) was a major contributing factor.</jats:p><jats:p> <jats:bold>Conclusions</jats:bold> Severe hypoglycaemia leading to hospital admission is more common in elderly Type 2 diabetic patients treated with long‐acting compared to short‐acting sulphonylureas. Such long‐acting sulphonylureas should be avoided.</jats:p> Higher incidence of severe hypoglycaemia leading to hospital admission in Type 2 diabetic patients treated with long‐acting versus short‐acting sulphonylureas Diabetic Medicine |
| spellingShingle | Stahl, M., Berger, W., Diabetic Medicine, Higher incidence of severe hypoglycaemia leading to hospital admission in Type 2 diabetic patients treated with long‐acting versus short‐acting sulphonylureas, Endocrinology, Endocrinology, Diabetes and Metabolism, Internal Medicine |
| title | Higher incidence of severe hypoglycaemia leading to hospital admission in Type 2 diabetic patients treated with long‐acting versus short‐acting sulphonylureas |
| title_full | Higher incidence of severe hypoglycaemia leading to hospital admission in Type 2 diabetic patients treated with long‐acting versus short‐acting sulphonylureas |
| title_fullStr | Higher incidence of severe hypoglycaemia leading to hospital admission in Type 2 diabetic patients treated with long‐acting versus short‐acting sulphonylureas |
| title_full_unstemmed | Higher incidence of severe hypoglycaemia leading to hospital admission in Type 2 diabetic patients treated with long‐acting versus short‐acting sulphonylureas |
| title_short | Higher incidence of severe hypoglycaemia leading to hospital admission in Type 2 diabetic patients treated with long‐acting versus short‐acting sulphonylureas |
| title_sort | higher incidence of severe hypoglycaemia leading to hospital admission in type 2 diabetic patients treated with long‐acting versus short‐acting sulphonylureas |
| title_unstemmed | Higher incidence of severe hypoglycaemia leading to hospital admission in Type 2 diabetic patients treated with long‐acting versus short‐acting sulphonylureas |
| topic | Endocrinology, Endocrinology, Diabetes and Metabolism, Internal Medicine |
| url | http://dx.doi.org/10.1046/j.1464-5491.1999.00110.x |